Anti-Microbial/Anti-fungal Test Market Outlook, Geography, Dynamics, and Insights by 2031

Coverage: By Test Type (Molecular Based Tests, Rapid Diagnostic Tests, complex Test, Phenotypic Resistance Tests, Others); Infection Type (Microbial Infection, Fungal Infection, Anti-Microbial Resistance, Anti-Fungal Resistance); End User (Hospitals and Clinics, Diagnostic Centers, Research Laboratories) , and Geography (North America, Europe, Asia Pacific, and South and Central America)

Historic Data: 2021-2023 | Base Year: 2024 | Forecast Period: 2025-2031
  • Status : Data Released
  • Report Code : TIPRE00005376
  • Category : Life Sciences
  • No. of Pages : 150
  • Available Report Formats : pdf-format excel-format
  • Last update date : February 12, 2026
Anti-Microbial/Anti-fungal Test Market Outlook, Geography, Dynamics, and Insights by 2031
Report Date: February 12, 2026   |   Report Code: TIPRE00005376 Email: sales@theinsightpartners.com

2024 Market Size

US$ 3.16 Bn

Base year value

2031 Forecast

US$ 5.07 Bn

Projected by 2031

CAGR 2025-2031

7.0 %

Growth rate

Addressable Market

US$ 29.26 Bn

(2025-2031)

The Anti Microbial Anti Fungal Test Market size is expected to reach US$ 5.07 billion by 2031. The market is anticipated to register a CAGR of 7.0% during 2025–2031.

The Infectious Disease Diagnostics Market is divided by test type into Molecular Based Tests, Rapid Diagnostic Tests, Complex Tests, Phenotypic Resistance Tests, and Others. It further categorizes the market by infection type, including Microbial Infection, Fungal Infection, Anti-Microbial Resistance, and Anti-Fungal Resistance, and end users, such as Hospitals and Clinics, Diagnostic Centers, and Research Laboratories. Projections through 2031 provide insights into how innovations in infectious disease diagnostics drive productivity and customer satisfaction. The global analysis is broken down at the regional level and major countries. The market evaluation is presented in US$ for the above segmental analysis.

Purpose of the Report

The report Anti-Microbial/Anti-fungal Test Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  1. Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  2. Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  3. Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Anti-Microbial/Anti-fungal Test Market Segmentation Test Type

  1. Molecular Based Tests
  2. Rapid Diagnostic Tests
  3. complex Test
  4. Phenotypic Resistance Tests
  5. Others

Infection Type

  1. Microbial Infection
  2. Fungal Infection
  3. Anti-Microbial Resistance
  4. Anti-Fungal Resistance

End User

  1. Hospitals and Clinics
  2. Diagnostic Centers
  3. Research Laboratories

Geography

  1. North America
  2. Europe
  3. Asia-Pacific
  4. South and Central America
  5. Middle East and Africa

Market Assessment and Insights

  • Global market for Anti-Microbial/Anti-fungal Test was valued at US$ 3.16 Billion in 2024
  • Annual market size is expected to reach US$ 5.07 Billion by 2031
  • Total addressable market (TAM) during 2025-2031 is projected to reach approximately US$ 29.26 Billion
  • Market is anticipated to register a CAGR of 7% during the forecast period
  • The United States represents a key market, supported by Increasing Antimicrobial Resistance (AMR), Growing Diseases, Diagnostic Tools Improve with New Technology, as well as evolving industry dynamics
  • Market analysis covers North America, Europe, Asia-Pacific, South and Central America, Middle East and Africa, with growth evaluated across the forecast period
  • Market opportunities such as Expand in Developing Markets, Customized Antibiotic Therapy, Expanded in Veterinary Sector are expected to influence market dynamics and addressable market
  • Report profiles industry participants, including bioMerieux, SA, Thermo Fisher Scientific Inc, Qiagen N. V, Bio-Rad Laboratories Inc, F. Hoffmann-La Roche Ltd, Erba Mannheim, Omega Diagnostics Group Plc, Quidel Corporation, Luminex Corporation, Norgen Biotek Corp, Abbott Laboratories, Bruker Corporation, Danaher Corporation, Erba Mannheim., Meridian Bioscience Inc, while analyzing competitive strategies and innovation developments
  • Source: The Insight Partners' analysis based on proprietary research, government publications, company annual reports, investor presentations, industry databases, and expert interviews.

● REPORT CUSTOMIZATION

Tailor This Report To Align With Your Specific Business Requirements

This report can be customized to align precisely with your business objectives, scope, and target markets. Customization options include tailored segmentation, geography, competitive analysis, and strategic insights to support informed decision-making.

Customize This Report →

WHAT YOU CAN ADJUST

  • Segmentations
  • Geography
  • Competitive Analysis
  • Language Preferences

Anti-Microbial/Anti-fungal Test Market: Strategic Insights

anti-microbial-anti-fungal-test-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Anti-Microbial/Anti-fungal Test Market Growth Drivers

  1. Increasing Antimicrobial Resistance (AMR): Increase in Antimicrobial resistance (AMR) is one of the main factor driving the antimicrobial/anti-fungal test market growth. When infection is resistant to existing antibiotics and antifungals, a growing need for accurate diagnostics to recognise resistant infections is in order.
  2. Growing Diseases: Global rise in fungal and bacterial diseases especially among immunocompromised patient are increasing the need for Antimicrobial and Antifungal test solutions. It is driven by the expanding epidemic of infectious diseases such as pneumonia, candidiasis and tuberculosis.
  3. Diagnostic Tools Improve with New Technology: Developments in molecular diagnosis, PCR, rapid test technologies are facilitating faster and more accurate testing of antimicrobial and antifungal agents. These developments are helping clinicians make the best treatment decisions and fight drug-resistant infections.

Anti-Microbial/Anti-fungal Test Market Future Trends

  1. Faster Diagnostic Testing: The use of fast diagnosis testing for microbiological infections is trending. Quick-result, real-time tests are now used extensively in hospitals and health care facilities to expedite diagnosis and treatment of infections in the intensive care setting.
  2. Use of Next-Generation Sequencing (NGS): NGS is becoming popular because it can detect almost any kind of pathogen, even the ones that can be hard to test for with standard methods. In clinical microbiology, NGS microbial-selection tests are now more widely used.
  3. Remain Targeted on Point-of-Care Diagnostics: Point-of-care (POC) diagnostics are increasingly being used to detect microbial infections in real time. These tests allow more time for diagnosis, which makes it possible to make treatment decisions faster, especially in a situation like an emergency room.

Anti-Microbial/Anti-fungal Test Market Opportunities

  1. Expand in Developing Markets: Growing rates of infections in developing countries, coupled with improved healthcare facilities open tremendous prospects for antimicrobial/antifungal testing in developing markets. With the increasing adoption of cutting edge diagnostic tools there is an ample growth potential.
  2. Customized Antibiotic Therapy: With personalized medicine becoming more important, it is now possible to apply antimicrobial testing to individualize antibiotic therapy. This will prevent the abuse of antibiotics and antimicrobial resistance.
  3. Expanded in Veterinary Sector: Antimicrobial/antifungal test market not only expands in the human field, but in the veterinary industry as well. Animal health diagnostics are more in demand, especially in the animal agriculture sector where antimicrobial testing is crucial to identifying animal infections.

Anti-Microbial/Anti-fungal Test Market Report Scope

Report Attribute Details
Market size in 2024 US$ 3.16 Billion
Market Size by 2031 US$ 5.07 Billion
Global CAGR (2025 - 2031) 7.0%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Test Type
  • Molecular Based Tests
  • Rapid Diagnostic Tests
  • complex Test
  • Phenotypic Resistance Tests
  • Others
By Infection Type
  • Microbial Infection
  • Fungal Infection
  • Anti-Microbial Resistance
  • Anti-Fungal Resistance
By End User
  • Hospitals and Clinics
  • Diagnostic Centers
  • Research Laboratories
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • bioMerieux, SA
  • Thermo Fisher Scientific Inc
  • Qiagen N. V
  • Bio-Rad Laboratories Inc
  • F. Hoffmann-La Roche Ltd
  • Erba Mannheim
  • Omega Diagnostics Group Plc
  • Quidel Corporation
  • Luminex Corporation
  • Norgen Biotek Corp
  • Abbott Laboratories
  • Bruker Corporation
  • Danaher Corporation
  • Erba Mannheim.

Anti-Microbial/Anti-fungal Test Market Players Density: Understanding Its Impact on Business Dynamics

The Anti-Microbial/Anti-fungal Test Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

anti-microbial-anti-fungal-test-market-cagr

Key Selling Points

  1. Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Anti-Microbial/Anti-fungal Test Market, providing a holistic landscape.
  2. Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
  3. Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
  4. Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

The research report on the Anti-Microbial/Anti-fungal Test Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.


Frequently Asked Questions

Some of the key drivers include increasing prevalence of antimicrobial resistance, rising fungal infections, and the growing demand for rapid diagnostic tests.

Key trends in the market include shift towards molecular diagnostics, use of point-of-care testing devices, and development of next-generation antimicrobial drugs.

Anti-Microbial/Anti-fungal Test Market is likely to be 4.98% in the forecast period (2024-2031).

The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.

Leading players include: bioMerieux, Inc, Thermo Fisher Scientific Inc, Qiagen N. V, Bio-Rad Laboratories Inc, F. Hoffmann-La Roche Ltd, Erba Mannheim, Omega Diagnostics Group Plc, Quidel Corporation, Luminex Corporation, Norgen Biotek Corp,

Some of the customization options available based on request are additional 3-5 company profiles and country-specific analysis of 3-5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Comprehensive Market Sizing and Forecast Analysis
  • Detailed Segmentation Analysis
  • In-Depth Market Dynamics Assessment
  • Regional and Country-Level Insights
  • Competitive Landscape and Company Benchmarking
  • Strategic Business Intelligence

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA